FYERS
Home
/
Stocks
/
Results
/
Johnson Pharmacare Results

Johnson Pharmacare Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
---0%
----198%
-8%-7%-43%
0%-1%-1%-1%

Peer Comparison

Symbol
ADANIENT-A
AEGISLOG-A
CPPLUS-A
PREMIERENE-A
REDINGTON-A
HONASA-A
LLOYDSENT-A
CELLO-A
JSLL-A
SREEL-T
JOHNPHARMA-X
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
2,920₹404763 Cr54.37-8.91105.06₹9339 Cr
1,373.5₹49337 Cr39.4313.841.65₹898 Cr
3,798.85₹45264 Cr94.8412.0745.29₹368 Cr
898₹41326 Cr24.8210.245.28₹1510 Cr
406.45₹31353 Cr18.436.2224.36₹1490 Cr
475.35₹15804 Cr63.52.778.99₹200 Cr
75.52₹11326 Cr100.860.380.91₹283 Cr
340.15₹7311 Cr23.373.3217.46₹332 Cr
511.55₹6517 Cr27.565.3123.32₹222 Cr
299.95₹673 Cr20.513.0214.74₹29 Cr
0.44₹24 Cr—-0.02-1.03-₹56 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
———————————————————
₹55 Cr₹55 Cr₹55 Cr₹55 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹50 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹10 Cr₹0₹0₹0
₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹9 Cr₹9 Cr₹9 Cr₹9 Cr₹2 Cr-₹24 L-₹3 L-₹3 L
₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹8 Cr₹9 Cr₹9 Cr₹9 Cr₹9 Cr₹2 Cr-₹24 L-₹3 L-₹3 L
₹56 Cr₹57 Cr₹57 Cr₹58 Cr₹58 Cr₹58 Cr₹58 Cr₹58 Cr₹58 Cr₹58 Cr₹58 Cr₹59 Cr₹59 Cr₹59 Cr₹59 Cr₹22 Cr₹10 Cr₹10 Cr₹10 Cr
₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹61 L₹2 Cr₹1 Cr
₹0₹1 Cr₹1 Cr₹0₹8 L₹2 L₹1 Cr₹1 Cr₹0₹0₹0₹0₹0₹0₹7 Cr₹7 Cr₹6 Cr₹6 L₹82 L
₹0₹0₹0₹0₹0₹0₹2 L₹2 L₹2 L₹2 L₹2 L₹2 L₹2 L₹2 L₹3 L₹3 L₹2 L₹2 L₹1 L
₹61 L₹2 Cr₹2 Cr₹61 L₹69 L₹63 L₹2 Cr₹2 Cr₹63 L₹63 L₹63 L₹63 L₹63 L₹63 L₹7 Cr₹8 Cr₹7 Cr₹2 Cr₹2 Cr
———————————————————
₹0₹0₹0₹0₹65 L₹56₹56₹56₹56₹56₹42 L₹43 L₹6 L₹37,231₹12 L₹38 L₹18 L₹10 L₹1 Cr
₹1 Cr₹1 Cr₹98 L₹1 Cr₹14,126₹10,000₹10,000₹10,000₹6 L₹5 L₹0₹0₹0₹0₹0₹0₹9 L₹5 L₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹50 L₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹6,200₹1 L₹11 L
₹1 Cr₹1 Cr₹98 L₹1 Cr₹65 L₹10,056₹10,056₹10,056₹6 L₹5 L₹42 L₹93 L₹6 L₹37,231₹12 L₹38 L₹26 L₹16 L₹1 Cr
₹58 Cr₹60 Cr₹60 Cr₹60 Cr₹59 Cr₹59 Cr₹60 Cr₹60 Cr₹59 Cr₹59 Cr₹60 Cr₹60 Cr₹59 Cr₹59 Cr₹66 Cr₹30 Cr₹17 Cr₹12 Cr₹14 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
₹61 L₹2 Cr₹2 Cr₹61 L₹69 L₹63 L₹2 Cr₹2 Cr₹61 L₹61 L₹61 L₹1 Cr₹61 L₹61 L₹7 Cr₹8 Cr₹7 Cr₹2 Cr₹2 Cr
———————————————————
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹31 L₹31 L₹31 L₹31 L₹31 L₹31 L₹31 L₹16 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹29 L₹29 L₹28 L₹26 L₹23 L₹19 L₹12 L₹8 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹2 L₹2 L₹3 L₹5 L₹8 L₹12 L₹19 L₹8 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
₹42 Cr₹46 Cr₹46 Cr₹54 Cr₹52 Cr₹52 Cr₹53 Cr₹54 Cr₹54 Cr₹35 Cr₹54 Cr₹30 Cr₹19 Cr₹25 Cr₹40 Cr₹10 Cr₹7 Cr₹9 Cr₹1,000
₹42 Cr₹46 Cr₹46 Cr₹54 Cr₹52 Cr₹52 Cr₹53 Cr₹54 Cr₹54 Cr₹35 Cr₹54 Cr₹30 Cr₹19 Cr₹25 Cr₹40 Cr₹10 Cr₹7 Cr₹9 Cr₹1,000
₹14 Cr₹14 Cr₹14 Cr₹5 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹4 Cr₹17 Cr₹24 Cr₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹5 L₹10 L₹16 L₹21 L₹0₹0₹0₹0
₹57 Cr₹60 Cr₹60 Cr₹59 Cr₹54 Cr₹54 Cr₹55 Cr₹56 Cr₹55 Cr₹37 Cr₹56 Cr₹34 Cr₹24 Cr₹43 Cr₹66 Cr₹12 Cr₹9 Cr₹11 Cr₹2 Cr
———————————————————
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹8 Cr₹0₹14 Cr₹20 Cr₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹7 Cr
₹0₹0₹0₹1 Cr₹2 Cr₹92 L₹92 L₹0₹0₹13 Cr₹43 L₹8 Cr₹12 Cr₹16 Cr₹0₹87 L₹1 Cr₹74 L₹4 Cr
₹1 L₹14,000₹18,000₹4 L₹23 L₹28 L₹30 L₹33 L₹34 L₹34 L₹27 L₹26 L₹27 L₹26 L₹26 L₹27 L₹29 L₹37 L₹60 L
₹1 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹1 Cr₹3 Cr₹4 Cr₹3 Cr₹50,000₹50,000₹17 Cr₹7 Cr₹45 L₹31 L
₹1 Cr₹14,000₹18,000₹1 Cr₹6 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹22 Cr₹4 Cr₹26 Cr₹36 Cr₹16 Cr₹27 L₹18 Cr₹8 Cr₹2 Cr₹12 Cr
₹21 L-₹1 Cr-₹97 L-₹4 L₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹22 Cr₹3 Cr₹25 Cr₹36 Cr₹16 Cr₹15 L₹18 Cr₹8 Cr₹1 Cr₹10 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹46,709₹0₹0₹0
₹58 Cr₹60 Cr₹60 Cr₹60 Cr₹59 Cr₹59 Cr₹60 Cr₹60 Cr₹59 Cr₹59 Cr₹60 Cr₹60 Cr₹59 Cr₹59 Cr₹66 Cr₹30 Cr₹17 Cr₹12 Cr₹14 Cr
₹1₹1₹1₹1₹12₹12₹12₹12₹12₹12₹12₹12₹12₹12₹12₹12₹10₹10₹10
₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1₹1

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
-₹58 L-₹20 L-₹1 Cr₹13 L₹11,742-₹9 L-₹1 L-₹6 L-₹8 L-₹13 L-₹7 L-₹8 L-₹11 L-₹6 L-₹13 L-₹1 L-₹23 L-₹9 L₹4 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹68,377₹1 L₹2 L₹3 L₹4 L₹4 L-₹2 L-₹2 L
-₹1 Cr₹15 L₹89 L₹5 Cr-₹11 L₹26 L-₹92 L-₹78 L₹11 Cr-₹11 Cr₹8 Cr₹4 Cr₹72 L-₹16 Cr-₹6 Cr-₹10 Cr-₹6 Cr₹9 Cr-₹4 Cr
-₹2 Cr-₹5 L-₹44 L₹5 Cr-₹11 L₹17 L-₹93 L-₹85 L₹11 Cr-₹11 Cr₹8 Cr₹4 Cr₹62 L-₹16 Cr-₹6 Cr-₹10 Cr-₹7 Cr₹9 Cr-₹4 Cr
-₹2 Cr-₹5 L-₹40 L₹5 Cr-₹11 L₹17 L-₹93 L-₹85 L₹11 Cr-₹11 Cr₹8 Cr₹4 Cr₹60 L-₹16 Cr-₹7 Cr-₹10 Cr-₹7 Cr₹9 Cr-₹4 Cr
₹3 Cr₹0-₹94 L-₹5 Cr₹0₹88 L₹90 L-₹25 L-₹11 Cr₹11 Cr-₹10 Cr-₹4 Cr-₹13 Cr₹16 Cr-₹30 Cr-₹3 Cr₹2 Cr-₹9 Cr₹4 Cr
-₹1 Cr₹5 L₹1 Cr-₹8 L₹6 L-₹1 Cr₹100₹1 Cr₹0₹10 L₹2 Cr₹56 L₹12 Cr₹45 L₹37 Cr₹13 Cr₹5 Cr-₹24 L₹2 L
₹1 L-₹4,000-₹4 L-₹19 L-₹5 L-₹3 L-₹3 L-₹78,878₹77,534₹6 L₹74,141-₹20,965₹99,155-₹70,905-₹91,351-₹2 L-₹8 L-₹23 L-₹19 L
₹14,000₹18,000₹4 L₹23 L₹28 L₹30 L₹33 L₹34 L₹34 L₹27 L₹26 L₹27 L₹26 L₹26 L₹27 L₹29 L₹37 L₹60 L₹78 L
₹1 L₹14,000₹18,000₹4 L₹23 L₹28 L₹30 L₹33 L₹34 L₹34 L₹27 L₹26 L₹27 L₹26 L₹26 L₹27 L₹29 L₹37 L₹60 L

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)0.44
Volume (₹)5.30 L
High (₹)0.45
Upper Circuit0.52
Low (₹)0.44
Lower Circuit0.36
Prev Close0.44
52W High (₹)0.78
Price0.44
52W Low (₹)0.43

Share Market Cap & Key Ratios Overview

M.Cap (₹)24.20 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.01
Price to Book0.91
Book Value1.02
EPS (TTM)-1.03
Face Value1.00
ROE (%)-1.03

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
SREEL-TNSE
JOHNPHARMA-XNSE
LTP
1W Low
1W High
Market cap (₹)
2920-79.1 (-2.64%)
2900
3025
4,04,763Cr
1373.5-43.75 (-3.09%)
1347.50
1528
49,337Cr
3798.85+447 (13.34%)
3344.30
3875.70
45,264Cr
898-5 (-0.55%)
885.10
919.30
41,326Cr
406.45+6.75 (1.69%)
390.60
419.55
31,353Cr
475.35-4.25 (-0.89%)
466
491.75
15,804Cr
75.52+6.73 (9.78%)
67.25
77.10
11,326Cr
340.15+17.6 (5.46%)
314.90
344.10
7,311Cr
511.55+1.9 (0.37%)
505
530.50
6,517Cr
299.95+13.15 (4.59%)
266.60
305
673Cr
0.44-0.02 (-4.35%)
0.43
0.47
24Cr

Johnson Pharmacare Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Johnson Pharmacare Ltd Quaterly Results Key Takeaways